The Impact of Sodium-Glucose Co-Transporter-2 Inhibition on Insulin Resistance and Inflammation in Patients with Type 2 Diabetes: A Retrospective Study

The Impact of Sodium-Glucose Co-Transporter-2 Inhibition on Insulin Resistance and Inflammation in Patients with Type 2 Diabetes: A Retrospective Study

<i>Background and Objectives</i>: Insulin resistance (IR) is a key factor involved in the development of type 2 diabetes (T2D). Besides its role in the pathogenesis of T2D, insulin resistance is associated with impairment of glycemic control, reduced achievement of glycemic targets, and...

Full description

Saved in:

Bibliographic Details
Main Authors:	Liana Iordan, Sandra Lazar, Romulus Timar, Simona Popescu, Teodora Sorescu, Oana Albai, Adina Braha, Bogdan Timar, Laura Gaita
Format:	Article
Language:	English
Published:	MDPI AG 2025-01-01
Series:	Medicina
Subjects:	insulin resistance inflammation sodium-glucose co-transporter 2 inhibitors estimated glucose disposal rate
Online Access:	https://www.mdpi.com/1648-9144/61/2/209
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diabetes and Cataracts Development—Characteristics, Subtypes and Predictive Modeling Using Machine Learning in Romanian Patients: A Cross-Sectional Study
by: Adriana Ivanescu, et al.
Published: (2024-12-01)

Sodium-glucose cotransporter 2 inhibitor for the treatment of diabetic nephropathy
by: Kong Ling-li, et al.
Published: (2021-01-01)

Safety of SGLT2 Inhibitors and Urinary Tract Infections in Clinical Practice—A Cross-Sectional Study
by: Liana Iordan, et al.
Published: (2024-12-01)

The Usefulness of the Glucose Management Indicator in Evaluating the Quality of Glycemic Control in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring Sensors: A Cross-Sectional, Multicenter Study
by: Sandra Lazar, et al.
Published: (2025-03-01)

Association between non-insulin-based insulin resistance indicators and frailty progression: a national cohort study and mendelian randomization analysis
by: Hui Tian, et al.
Published: (2025-01-01)

Sodium-glucose cotransporter 2 inhibitors as potential anticancer agents
by: E. R. Radkevich, et al.
Published: (2025-05-01)

Sodium-Glucose Cotransporter-2 Inhibitor in Diabetic and Nondiabetic Renal Transplant Recipients
by: Lucie Maigret, et al.
Published: (2025-03-01)

Dysregulated renal tubular handling of filtered glucose in patients with type 2 diabetes mellitus: a descriptive study
by: Asim Zulfiqar, et al.
Published: (2024-10-01)

Perioperative euglycemic DKA: The YIN and YANG of sodium-glucose cotransporter 2 inhibitors
by: Shilpushp Bhosale, et al.
Published: (2025-01-01)

Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
by: M. M. Batyushin
Published: (2021-04-01)

Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights
by: Han-Sang Baek, et al.
Published: (2024-11-01)

Association of sodium-glucose cotransporter-2 inhibitor use and mortality in patients with endometrial cancer: a retrospective cohort study
by: Min Wang, et al.
Published: (2025-07-01)

The role of sodium – glucose cotransporter-2 inhibitors in the treatment of different phenotypes of chronic heart failure
by: M. Yu. Kolesnyk, et al.
Published: (2024-03-01)

Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis
by: Sadia Bari, et al.
Published: (2025-06-01)

Association Between Estimated Glucose Disposal Rate and Stroke in Middle‐Aged and Older Chinese Adults: A Nationwide Prospective Cohort Study
by: Guijun Huo, et al.
Published: (2025-05-01)

Trends in prescribing sodium‐glucose cotransporter 2 inhibitors for individuals with type 2 diabetes with and without cardiovascular‐renal disease in South Korea, 2015–2021
by: Kyoung Hwa Ha, et al.
Published: (2025-02-01)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on insulin: a network meta-analysis
by: M. V. Shestakova, et al.
Published: (2025-01-01)

ALDH2 mediates the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on improving cardiac remodeling
by: Han Liu, et al.
Published: (2024-10-01)

Time spent in lifestyle activities is associated with better insulin sensitivity and physical fitness in a sedentary Mexican American male population
by: Jehu Apaflo, et al.
Published: (2025-03-01)

Antifibrotic effects of sodium-glucose cotransporter 2 inhibitors in patients with heart failure
by: Yu. S. Ignatova, et al.
Published: (2024-02-01)

Sodium glucose cotransporter 2 inhibitors are associated with renal stabilization in heart transplantation
by: Lisa M. Raven, MBBS, FRACP, et al.
Published: (2025-05-01)

Insulin resistance quantified by estimated glucose disposal rate predicts cardiovascular disease incidence: a nationwide prospective cohort study
by: Shiyi Tao, et al.
Published: (2025-04-01)

Impact of sodium–glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus: a comprehensive review
by: Thomas T. Yoo, et al.
Published: (2025-05-01)

Sodium-glucose cotransporter type 2 inhibitors: successful running after two hares
by: N. B. Perepech, et al.
Published: (2021-07-01)

Estimated Glucose Disposal Rate Associated With Risk of Frailty and Likelihood of Reversion
by: Dingchun Hou, et al.
Published: (2025-04-01)

Early Initiation of Sodium–Glucose Cotransporter 2 Inhibitors in Acute Heart Failure: A Systematic Review and Meta‐Analysis
by: Miloud Cherbi, et al.
Published: (2025-04-01)

Budget Impact and Cost–Benefit Analyses of Sodium-Glucose Cotransporter-2 Inhibitors for Patients With Heart Failure in Thailand
by: Arunmanakul P, et al.
Published: (2025-02-01)

Evaluating the link between insulin resistance and cognitive impairment using estimated glucose disposal rate in a non-diabetic aging population: results from the CHARLS
by: Bingqing Wang, et al.
Published: (2025-06-01)

Comparing the impact of cumulative insulin resistance surrogates exposure on stroke: optimizing prevention strategies
by: Dezhi Hong, et al.
Published: (2025-04-01)

Neurodevelopment of preterm infants with glucose and sodium abnormalities
by: Hui-Ying Yang, et al.
Published: (2021-11-01)

Evaluation of factors influencing adherence to treatment with sodium-glucose cotransporter type 2 inhibitor
by: D. A. Lebedev, et al.
Published: (2020-10-01)

Severe Hyponatremia Uncovering Secondary Adrenal Insufficiency: A Case Report
by: Oana Albai, et al.
Published: (2024-12-01)

Induction of proximal tubular proliferation and lengthening in response to sodium glucose linked cotransporter‐2 inhibition in experimental rats
by: Ellen Wu, et al.
Published: (2025-07-01)

Genomic insights about the effect of sodium-glucose cotransporter 2 inhibitors: a systematic review
by: Pavitraa Saravana Kumar, et al.
Published: (2025-05-01)

Association between estimated glucose disposal rate with the all-cause and cause-specific mortality among the population with cardiometabolic syndrome
by: Chao Fu, et al.
Published: (2025-02-01)

Insulin resistance assessed by estimated glucose disposal rate is associated with all-cause and cardiovascular mortality among postmenopausal women
by: Han Qian, et al.
Published: (2025-07-01)

Effects of Sodium–Glucose Co-Transporter 2 Inhibitors on Serum Chloride Concentrations in Patients with Heart Failure
by: Ivana Jurin, et al.
Published: (2024-11-01)

Association of sodium–glucose cotransporter-2 inhibitors with mortality across the spectrum of myocardial infarction: a systematic review and meta-analysis
by: Michele Maremmani, et al.
Published: (2025-01-01)

Associations of estimated glucose disposal rate with frailty progression: results from two prospective cohorts
by: Zhaoping Wang, et al.
Published: (2025-02-01)

A case of pyelonephritis and bacteremia caused by Candida glabrata in a patient on sodium glucose cotransporter 2 inhibitor, successfully treated with micafungin
by: Shoko Sahara, et al.
Published: (2025-08-01)